BioAro Ships AI-Formulated Supplements. The Algorithm Picks Your Ingredients. Whether It Should Is Another Question Entirely.

BioAro has launched its AI-assisted LONgevity+ Bioactives portfolio in the U.S. and U.K. markets following a debut in Dubai. The system, called BioAro Intelligence, lets users start with a health goal and then explores structured protocols that combine products, formulas, ingredients, and scientific context. The CREAGEN series includes Brain Boost, Raw Power, Pro Power, and Femme Energy formulations targeting daily wellness, cognition, energy, performance, and recovery.

This demonstrates protocol-based recommendation engines, where AI organizes multiple interventions around a stated objective rather than suggesting a single product. The mechanism is goal-directed composition: the system maps a wellness target to a structured stack of ingredients and supporting science. The broader BioAro ecosystem spans genomics, multi-omics, microbiome science, and drug discovery, which means the recommendation logic draws from a deep biological data foundation. The reader should understand that AI in wellness is shifting from single-product suggestions to orchestrated, multi-layered protocols.

BioAro has expanded its precision longevity portfolio to the U.S. and U.K. after launching in Dubai. Its ecosystem spans precision health, genomics, multi-omics, microbiome science, diagnostics, AI, and drug discovery, with CREAGEN formulations covering cognition, energy, performance, and recovery.